Document is current
Any future updates will be listed below
-
Authors
Marderstein, Andrew R. http://orcid.org/0000-0003-0859-4969
Uppal, Manik http://orcid.org/0000-0003-3628-1716
Verma, Akanksha
Bhinder, Bhavneet
Tayyebi, Zakieh http://orcid.org/0000-0002-7821-9905
Mezey, Jason
Clark, Andrew G. http://orcid.org/0000-0001-7159-8511
Elemento, Olivier
-
Funding
Funding for this research was provided by:
U.S. Department of Health & Human Services | NIH | National Institute of General Medical Sciences (5T32GM083937-10)
- License Information
-
More Information
Article History
Received: 27 April 2019
Accepted: 13 April 2020
First Online: 5 May 2020
Competing interests
: O.E. is scientific advisor and equity holder in Freenome, Owkin, Volastra Therapeutics and One Three Biotech.
